Original Research

Published on 15 Jan 2024

Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer’s disease diagnosis

in Alzheimer's Disease and Related Dementias

Xinyu Li
Huimei Zeng
Pradeepraj Durairaj
Weihuan Wen
Tianpeng Li
Yanru Zhao
Yang Liu
Xue Liu
Lingpeng Zhan
Lang Rao

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1340706

3,462 views

Perspective

Published on 12 Jan 2024

From theory to practice: translating the concept of cognitive resilience to novel therapeutic targets that maintain cognition in aging adults

in Alzheimer's Disease and Related Dementias

Andrea R. Zammit
David A. Bennett
Aron S. Buchman

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1303912

2,556 views
3 citations

Brief Research Report

Published on 11 Jan 2024

Estimating dementia risk in an African American population using the DCTclock

in Alzheimer's Disease and Related Dementias

Marissa Ciesla
Jeff Pobst
Joyce Gomes-Osman
Melissa Lamar
Lisa L. Barnes
Russell Banks
Ali Jannati
David Libon
Rodney Swenson
Sean Tobyne

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1328333

2,241 views

Editorial

Published on 11 Jan 2024

Editorial: Neurotoxins in Alzheimer's disease and other dementias

in Alzheimer's Disease and Related Dementias

Alexandre Henriques
Philippe Léon Louis Poindron
Binosha Fernando
Kevin N. Hascup

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2024.1363466

2,262 views

Original Research

Published on 11 Jan 2024

Effect of hormone replacement therapy on amyloid beta (Aβ) plaque density in the rhesus macaque amygdala

in Alzheimer's Disease and Related Dementias

Maria-Luisa Appleman
Jeremy L. Thomas
Alison R. Weiss
Benjamin I. Nilaver
Rita Cervera-Juanes
Steven G. Kohama
Henryk F. Urbanski

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1326747

2,160 views
3 citations

Original Research

Published on 11 Jan 2024

Effects of remote combine exercise-music training on physical and cognitive performance in patients with Alzheimer’s disease: a randomized controlled trial

in Alzheimer's Disease and Related Dementias

Ghazaleh Shokri
Fatemeh Mohammadian
Maryam Noroozian
Sadegh Amani-Shalamzari
Katsuhiko Suzuki

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1283927

4,030 views
3 citations

Correction

Published on 09 Jan 2024

Corrigendum: Causal associations between common musculoskeletal disorders and dementia: a Mendelian randomization study

in Alzheimer's Disease and Related Dementias

Jiachen Wang
Mingyi Yang
Ye Tian
Ruoyang Feng
Ke Xu
Menghao Teng
Junxiang Wang
Qi Wang
Peng Xu

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1362700

1,430 views

Editorial

Published on 09 Jan 2024

Editorial: Quantitative imaging methods and analysis in Alzheimer's disease assessment

in Alzheimer's Disease and Related Dementias

Stephanos Leandrou
Deqiang Qiu
Constantino Carlos Reyes-Aldasoro

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1340877

2,026 views

Review

Published on 08 Jan 2024

Unravelling the connection between COVID-19 and Alzheimer’s disease: a comprehensive review

in Alzheimer's Disease and Related Dementias

Shah Rezlan Shajahan
Suresh Kumar
Muhammad Danial Che Ramli

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1274452

12,337 views
4 citations

Editorial

Published on 08 Jan 2024

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: molecular mechanisms, biomarkers, diagnosis, and therapies, volume III

in Alzheimer's Disease and Related Dementias

Jiehui Jiang
Kuangyu Shi
Kenneth S. Hettie
Chih-Yu Hsu
Woon-Man Kung

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1352988

1,748 views

Original Research

Published on 08 Jan 2024

Aging or chronic stress impairs working memory and modulates GABA and glutamate gene expression in prelimbic cortex

in Alzheimer's Disease and Related Dementias

Hannah M. Gandy
Fiona Hollis
Caesar M. Hernandez
Joseph A. McQuail

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1306496

2,763 views
2 citations

Original Research

Published on 04 Jan 2024

Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis

in Alzheimer's Disease and Related Dementias

Xiaobei Pan
Paul C. Donaghy
Gemma Roberts
Leonidas Chouliaras
John T. O’Brien
Alan J. Thomas
Amanda J. Heslegrave
Henrik Zetterberg
Bernadette McGuinness
Anthony P. Passmore

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1326780

3,542 views

Retraction

Published on 28 Dec 2023

Retraction: ADVIAN: Alzheimer's disease VGG-inspired attention network based on convolutional block attention module and multiple way data augmentation

in Alzheimer's Disease and Related Dementias

Frontiers Editorial Office

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1358292

3,320 views

Original Research

Published on 22 Dec 2023

Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Yuye Wang
Yu Sun
Yu Wang
Shuhong Jia
Yanan Qiao
Zhi Zhou
Wen Shao
Xiangfei Zhang
Jing Guo
Xincheng Song

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1273807

4,645 views
1 citation

Methods

Published on 20 Dec 2023

A systematic review for the development of Alzheimer’s disease in in vitro models: a focus on different inducing agents

in Alzheimer's Disease and Related Dementias

Manisha Prajapat
Gurjeet Kaur
Gajendra Choudhary
Paras Pahwa
Seema Bansal
Rupa Joshi
Gitika Batra
Abhishek Mishra
Rubal Singla
Harminder Kaur

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1296919

6,197 views
1 citation

Review

Published on 19 Dec 2023

Copper and cuproptosis: new therapeutic approaches for Alzheimer’s disease

in Alzheimer's Disease and Related Dementias

Xiao Li
Xinwang Chen
Xiyan Gao

Frontiers in Aging Neuroscience

doi 10.3389/fnagi.2023.1300405

5,347 views
7 citations

Navigation group

Articles

Fully synthetic phosphorylated Tau181, Tau217, and Tau231 calibrators for Alzheimer’s disease diagnosis

From theory to practice: translating the concept of cognitive resilience to novel therapeutic targets that maintain cognition in aging adults

Estimating dementia risk in an African American population using the DCTclock

Editorial: Neurotoxins in Alzheimer's disease and other dementias

Effect of hormone replacement therapy on amyloid beta (Aβ) plaque density in the rhesus macaque amygdala

Effects of remote combine exercise-music training on physical and cognitive performance in patients with Alzheimer’s disease: a randomized controlled trial

Corrigendum: Causal associations between common musculoskeletal disorders and dementia: a Mendelian randomization study

Editorial: Quantitative imaging methods and analysis in Alzheimer's disease assessment

Unravelling the connection between COVID-19 and Alzheimer’s disease: a comprehensive review

Editorial: Translational advances in Alzheimer's, Parkinson's, and other dementia: molecular mechanisms, biomarkers, diagnosis, and therapies, volume III

Aging or chronic stress impairs working memory and modulates GABA and glutamate gene expression in prelimbic cortex

Plasma metabolites distinguish dementia with Lewy bodies from Alzheimer’s disease: a cross-sectional metabolomic analysis

Retraction: ADVIAN: Alzheimer's disease VGG-inspired attention network based on convolutional block attention module and multiple way data augmentation

Urine metabolomics phenotyping and urinary biomarker exploratory in mild cognitive impairment and Alzheimer’s disease

A systematic review for the development of Alzheimer’s disease in in vitro models: a focus on different inducing agents

Copper and cuproptosis: new therapeutic approaches for Alzheimer’s disease